Adrenocortical steroid response to ACTH in different phenotypes of non-obese polycystic ovary syndrome

Journal of Ovarian Research

Volumn 5, Issue 1, 2012, Pages

  Cinar, Nese ^a   Harmanci, Ayla ^a   Aksoy, Duygu Yazgan ^a   Aydin, Kadriye ^a   Yildiz, Bulent Okan ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

ACTH; Adrenal androgen; DHEAS; PCOS

Indexed keywords

ANDROGEN; ANDROSTENEDIONE; CORTICOTROPIN; HYDROCORTISONE; HYDROXYPROGESTERONE; PRASTERONE SULFATE; SEX HORMONE BINDING GLOBULIN; STEROID; TESTOSTERONE;

ADRENAL GLAND; ADULT; ANDROGEN RELEASE; ANOVULATION; ARTICLE; CONTROLLED STUDY; CORTICOTROPIN TEST; FEMALE; HORMONE RESPONSE; HUMAN; HYPERANDROGENISM; MAJOR CLINICAL STUDY; OVARY POLYCYSTIC DISEASE; PHENOTYPE; PRIORITY JOURNAL;

EID: 84870496619     PISSN: None     EISSN: 17572215     Source Type: Journal    
DOI: 10.1186/1757-2215-5-42     Document Type: Article

References (45)

1. The prevalence and features of the polycystic ovary syndrome in an unselected population. Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES, Yildiz BO, J Clin Endocrinol Metab 2004 89 2745 2749 10.1210/jc.2003-032046 15181052 (Pubitemid 38766360)
2. Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. Zawadski JK, Dunaif A, Current Issues in Endocrinology and Metabolism Blackwell, Boston MA 1992 377 384
3. Revised 2003 consensus on diagnostic criteria and long term health risks related to polycystic ovary syndrome. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group, Fertil Steril 2004 81 19 25 15126094
4. The prevalence and significance of elevated dehydroepiandrosterone sulfate levels in anovulatory women. Hoffman DI, Klove K, Lobo RA, Fertil Steril 1984 42 76 81 6327404 (Pubitemid 14086154)
5. Testosterone, dehydroepiandrosterone, and dehydroepiandrosterone sulfate in hyperandrogenic women. Steinberger E, Smith KD, Rodriguez-Rigau LJ, J Clin Endocrinol Metab 1984 59 471 477 10.1210/jcem-59-3-471 6235239 (Pubitemid 14031791)
6. Increased DHEAs levels in PCO syndrome: evidence for the existence of two subgroups of patients. Carmina E, Rosato F, Janni A, J Endocrinol Invest 1986 9 5 9 3009597 (Pubitemid 16073579)
7. Steroid responses to ACTH in women with polycystic ovaries. Hague WM, Honour JW, Adams J, Vecsei P, Jacobs HS, Clin Endocrinol (Oxf) 1989 30 4 355 365 10.1111/j.1365-2265.1989.tb00433.x (Pubitemid 19110007)
8. The adrenal and polycystic ovary syndrome. Yildiz BO, Azziz R, Rev Endocr Metab Disord 2007 8 331 342 10.1007/s11154-007-9054-0 17932770
9. Clinical and biological phenotypes in late-onset 21-hydroxylase deficiency. Dewailly D, Vantyghem-Haudiquet MC, Sainsard C, Buvat J, Cappoen JP, Ardaens K, Racadot A, Lefebvre J, Fossati P, J Clin Endocrinol Metab 1986 63 418 423 10.1210/jcem-63-2-418 3013919
10. 21-Hydroxylase-deficient nonclassic adrenal hyperplasia is a progressive disorder: a multicenter study. Moran C, Azziz R, Carmina E, Dewailly D, Fruzzetti F, Ibanez L, Knochenhauer ES, Marcondes JA, Mendonca BB, Pignatelli D, Pugeat M, Rohmer V, Speiser PW, Witchel SF, Am J Obstet Gynecol 2000 183 1468 1474 10.1067/mob.2000.108020 11120512 (Pubitemid 32061209)
11. Evidence for the importance of peripheral tissue events in the development of hirsutism in polycystic ovary syndrome. Lobo RA, Goebelsmann U, Horton R, J Clin Endocrinol Metab 1983 57 393 397 10.1210/jcem-57-2-393 6223045 (Pubitemid 13032496)
12. Girls diagnosed with premature pubarche show an exaggerated ovarian androgen synthesis from the early stages of puberty: evidence from gonadotropin-releasing hormone agonist testing. Ibanez L, Potau N, Zampolli M, Street ME, Carrascosa A, Fertil Steril 1997 67 849 855 10.1016/S0015-0282(97) 81396-9 9130889 (Pubitemid 27183913)
13. Adrenal androgen production capacity remains high up to menopause in women with polycystic ovary syndrome. Puurunen J, Piltonen T, Jaakkola P, Ruokonen A, Morin-Papunen L, Tapanainen JS, J Clin Endocrinol Metab 2009 94 1973 1978 10.1210/jc.2008-2583 19318449
14. Stability of adrenocortical steroidogenesis over time in healthy women and women with polycystic ovary syndrome. Yildiz BO, Woods KS, Stanczyk F, Bartolucci A, Azziz R, J Clin Endocrinol Metab 2004 89 5558 5562 10.1210/jc.2004-0934 15531511 (Pubitemid 39518440)
15. Heritability of dehydroepiandrosterone sulfate in women with polycystic ovary syndrome and their sisters. Yildiz BO, Goodarzi MO, Guo X, Rotter JI, Azziz R, Fertil Steril 2006 86 1688 1693 10.1016/j.fertnstert.2006.05.045 17074350
16. High serum dehydroepiandrosterone sulfate is associated with phenotypic acne and a reduced risk of abdominal obesity in women with polycystic ovary syndrome. Chen MJ, Chen CD, Yang JH, Chen CL, Ho HN, Yang WS, Yang YS, Hum Reprod 2011 26 227 234 10.1093/humrep/deq308 21088016
17. Insulin resistance and endocrine characteristics of the different phenotypes of polycystic ovary syndrome: a prospective study. Panidis D, Tziomalos K, Misichronis G, Papadakis E, Betsas G, Katsikis I, Macut D, Hum Reprod 2012 27 541 549 10.1093/humrep/der418 22144419
18. Characteristics of different phenotypes of polycystic ovary syndrome based on the Rotterdam criteria in a large-scale Chinese population. Zhang HY, Zhu FF, Xiong J, Shi XB, Fu SX, BJOG 2009 116 1633 1639 10.1111/j.1471-0528. 2009.02347.x 19781047
19. Increased circulating soluble P-selectin in polycystic ovary syndrome. Yildiz BO, Bozdag G, Harmanci A, Otegen U, Boynukalin K, Vural Z, Kirazli S, Haznedaroglu IC, Yarali H, Fertil Steril 2010 93 2311 2315 10.1016/j.fertnstert. 2009.01.121 19261277
20. Postpubertal outcome in girls diagnosed of premature pubarche during childhood: increased frequency of functional ovarian hyperandrogenism. Ibanez L, Potau N, Virdis R, Zampolli M, Terzi C, Gussinye M, Carrascosa A, Vicens-Calvet E, J Clin Endocrinol Metab 1993 76 1599 1603 10.1210/jc.76.6.1599 8501168 (Pubitemid 23164385)
21. Adrenal androgen hyperresponsiveness to adrenocorticotropin in women with acne and/or hirsutism: adrenal enzyme defects and exaggerated adrenarche. Lucky AW, Rosenfield RL, McGuire J, Rudy S, Helke J, J Clin Endocrinol Metab 1986 62 840 848 10.1210/jcem-62-5-840 3007557 (Pubitemid 16106706)
22. Adrenal function during childhood and puberty in daughters of women with polycystic ovary syndrome. Maliqueo M, Sir-Petermann T, Perez V, Echiburu B, de Guevara AL, Galvez C, Crisosto N, Azziz R, J Clin Endocrinol Metab 2009 94 3282 3288 10.1210/jc.2009-0427 19567527
23. Cross-sectional analysis of the effects of age on the hormonal, metabolic, and ultrasonographic features and the prevalence of the different phenotypes of polycystic ovary syndrome. Panidis D, Tziomalos K, Macut D, Delkos D, Betsas G, Misichronis G, Katsikis I, Fertil Steril 2012 97 2 494 500 10.1016/j.fertnstert.2011.11.041 22192350
24. Adrenal androgen excess in the polycystic ovary syndrome: sensitivity and responsivity of the hypothalamic-pituitary-adrenal axis. Azziz R, Black V, Hines GA, Fox LM, Boots LR, J Clin Endocrinol Metab 1998 83 2317 2323 10.1210/jc.83.7.2317 9661602 (Pubitemid 28503021)
25. Ovarian-adrenal cross-talk in polycystic ovary syndrome: evidence from wedge resection. Wu XK, Zhou SY, Sallinen K, Pollanen P, Erkkola R, Eur J Endocrinol 2000 143 383 388 10.1530/eje.0.1430383 11022181
26. Determination of the source of androgen excess in functionally atypical polycystic ovary syndrome by a short dexamethasone androgen-suppression test and a low-dose ACTH test. Rosenfield RL, Mortensen M, Wroblewski K, Littlejohn E, Ehrmann DA, Hum Reprod 2011 26 11 3138 3146 10.1093/humrep/der291 21908468
27. Adrenal androgenic response to 2-hour ACTH stimulation test in women with PCOS. Erel CT, Senturk LM, Oral E, Colgar U, Ertungealp E, Gynecol Endocrinol 1998 12 223 229 10.3109/09513599809015594 9798131 (Pubitemid 28454368)
28. Role of ovary and adrenal glands in hyperandrogenemia in patients with polycystic ovary syndrome. Kamel N, Tonyukuk V, Emral R, Corapcioglu D, Bastemir M, Gullu S, Exp Clin Endocrinol Diabetes 2005 113 115 121 10.1055/s-2004-830540 15772904 (Pubitemid 40388783)
29. Pituitary-adrenal responses to ovine corticotropin-releasing factor in polycystic ovary syndrome and in other hyperandrogenic patients. Carmina E, Lobo RA, Gynecol Endocrinol 1990 4 225 232 10.3109/09513599009024976 1964538
30. Prevalence and metabolic characteristics of adrenal androgen excess in hyperandrogenic women with different phenotypes. Carmina E, Lobo RA, J Endocrinol Invest 2007 30 111 116 17392600 (Pubitemid 46614441)
31. ACTH stimulation tests and plasmadehydroepiandrosterone sulfate levels in women with hirsutism. Siegel SF, Finegold DN, Lanes R, Lee PA, N Engl J Med 1990 323 13 849 854 10.1056/NEJM199009273231301 2168515 (Pubitemid 20341554)
32. Investigation of adrenal functions in patients with idiopathic hyperandrogenemia. Atmaca H, Tanriverdi F, Unluhizarci K, Bayram F, Kelestimur F, Eur J Endocrinol 2006 155 307 311 10.1530/eje.1.02212 16868145 (Pubitemid 44269448)
33. Endocrine and metabolic differences among phenotypic expressions of polycystic ovary syndrome according to the 2003 Rotterdam consensus criteria. Kauffman RP, Baker TE, Baker VM, DiMarino P, Castracane VD, Am J Obstet Gynecol 2008 198 670 e671-677; discussion 670 e677-610 18355776
34. Cardiovascular risk in women with polycystic ovary syndrome. Orio F, Palomba S, Colao A, Fertil Steril 2006 86 Suppl 1 20 S21 16798279
35. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Dunaif A, Endocr Rev 1997 18 6 774 800 10.1210/er.18.6.774 9408743 (Pubitemid 28009567)
36. Insulin sensitivity after metformin suspension in normal-weight women with polycystic ovary syndrome. Palomba S, Falbo A, Russo T, Manguso F, Tolino A, Zullo F, De Feo P, Orio F Jr, J Clin Endocrinol Metab 2007 92 8 3128 3135 10.1210/jc.2007-0441 17519312 (Pubitemid 47236381)
37. Hyperinsulinemia and circulating dehydroepiandrosterone sulfate in white and Mexican American women with polycystic ovary syndrome. Kauffman RP, Baker VM, DiMarino P, Castracane VD, Fertil Steril 2006 85 1010 1016 10.1016/j.fertnstert.2005.09.046 16580388
38. Dehydroepiandrosterone sulfate and insulin resistance in patients with polycystic ovary syndrome. Brennan K, Huang A, Azziz R, Fertil Steril 2009 91 1848 1852 10.1016/j.fertnstert.2008.02.101 18439591
39. Opposing effects of dehydroepiandrosterone sulfate and free testosterone on metabolic phenotype in women with polycystic ovary syndrome. Lerchbaum E, Schwetz V, Giuliani A, Pieber TR, Obermayer-Pietsch B, Fertil Steril 2012 98 5 1318 1325 10.1016/j.fertnstert.2012.07.1057 22835450
40. Differential androgen response to adrenocorticotropic hormone stimulation in polycystic ovarian syndrome: relationship with insulin secretion. Lanzone A, Fulghesu AM, Guido M, Fortini A, Caruso A, Mancuso S, Fertil Steril 1992 58 296 301 1321739
41. Effect of pioglitazone treatment on the adrenal androgen response to corticotrophin in obese patients with polycystic ovary syndrome. Guido M, Romualdi D, Suriano R, Giuliani M, Costantini B, Apa R, Lanzone A, Hum Reprod 2004 19 3 534 539 10.1093/humrep/deh145 14998947 (Pubitemid 38344512)
42. Effects of metformin on adrenal steroidogenesis in women with polycystic ovary syndrome. la Marca A, Morgante G, Paglia T, Ciotta L, Cianci A, De Leo V, Fertil Steril 1999 72 6 985 989 10.1016/S0015-0282(99)00407-0 10593368
43. Glucose action and adrenocortical biosynthesis in women with polycystic ovary syndrome. Farah-Eways L, Reyna R, Knochenhauer ES, Bartolucci AA, Azziz R, Fertil Steril 2004 81 1 120 125 10.1016/j.fertnstert.2003.05.008 14711554 (Pubitemid 38058336)
44. Relative sensitivity and responsivity of serum cortisol and two adrenal androgens to alpha-adrenocorticotropin-(1-24) in normal and obese, nonhirsute, eumenorrheic women. Komindr S, Kurtz BR, Stevens MD, Karas JG, Bittle JB, Givens JR, J Clin Endocrinol Metab 1986 63 860 864 10.1210/jcem-63-4-860 3018027 (Pubitemid 16004287)
45. Secretion of major adrenal androgens following ACTH administration in obese women with different body fat distribution. Vicennati V, Calzoni F, Gambineri A, Gagliardi L, Morselli Labate AM, Casimirri F, Pasquali R, Horm Metab Res 1998 30 133 136 10.1055/s-2007-978851 9566854 (Pubitemid 28172519)